Low Dose Clozapine / Quetiapine Expert Views

Dr. Jennifer Goldman discusses the use of low-dose Clozapine and Quetiapine for treating psychosis in Parkinson's patients. She notes that Quetiapine has shown mixed results in clinical trials, with some positive impressions but inconsistent findings. Both drugs are used in low doses for Parkinson's psychosis, and common side effects include sedation and low blood pressure. Dr. Goldman emphasizes the importance of monitoring these side effects, especially since Parkinson's patients may already experience similar symptoms. She also highlights the risks of untreated psychosis, such as self-injury and harm to family members, and mentions a black box warning for elderly patients with dementia-related psychosis. A study on veterans showed negative outcomes like death and hospitalization in 40% of cases over a 180-day follow-up period, linked to worsened Parkinson's disease and other health issues.

Dr. David Shprecher explains that for patients with Parkinson's disease or related conditions like Lewy body dementia, it is crucial to avoid most antipsychotics for treating hallucinations, as they can worsen motor symptoms. He highlights that quetiapine (Seroquel) and pimavanserin (Nuplazid) are preferred options because they are less likely to exacerbate Parkinsonism. Specifically, pimavanserin does not worsen motor symptoms at all, and quetiapine, even at higher doses, is less likely to have this effect compared to other antipsychotics.

Dr. Dylan Wint discusses the use of low-dose Clozapine and Quetiapine for managing psychosis in Parkinson's disease. He emphasizes that delusions, such as those involving infidelity, are fixed beliefs that are not easily changed by evidence. In such cases, pharmacological treatments like Clozapine or Quetiapine may be considered to improve quality of life, especially in close relationships. He also notes that while medications like Seroquel (Quetiapine) can help with hallucinations and sleep, higher doses may worsen motor symptoms in Parkinson's patients.

Dr. Aaron Haug explains that low-dose Clozapine (Clozaril) and Quetiapine (Seroquel) can be used to manage hallucinations in Parkinson's patients. He emphasizes that these medications are generally managed by psychiatrists because Clozapine requires blood monitoring. He advises against using other antipsychotics like Haldol, Risperdal, Abilify, Zyprexa, and Geodon, as they block dopamine and can worsen Parkinson's motor symptoms. However, in severe cases of hallucinations or agitation, these medications might be used as a last resort.

The expert discusses the use of low-dose Clozapine and Quetiapine for treating psychosis and cognitive symptoms in Parkinson's disease. They highlight that these medications are generally safe and effective, especially in later stages when drug-induced effects like psychosis or hallucinations may occur. The expert also notes that treatment strategies for cognitive and psychosis symptoms are similar for Parkinson's and dementia with Lewy bodies, but emphasizes the importance of accurate diagnosis for planning and prognosis. Additionally, they touch on the role of deep brain stimulation in improving motor function and potentially reducing cognitive side effects, depending on electrode placement.

Dr. Ruchir Patel discusses the use of low-dose Quetiapine for Parkinson's patients, particularly in addressing sleep-related issues. He emphasizes the importance of balancing the risks and benefits of medications, noting that while Quetiapine can be effective at low doses, it is crucial to monitor for side effects at higher dosages. He also compares Quetiapine favorably to older medications like benzodiazepines, which he considers less safe. Dr. Patel highlights the need for individualized treatment plans, weighing the potential risks of falls against the benefits of improved sleep and overall quality of life.